Skip to main content

Profiles

Baruch S. Blumberg Institute

The Baruch S. Blumberg Institute is an American non-profit research institute based in Doylestown, Pennsylvania. It is a subsidiary of the Hepatitis B Foundation.[1]

History

The institute was founded in 2003.[1:1]

Funding

The institute has received funding from:[2][3][4]

  • America's Charities
  • Amgen Foundation
  • Arcinova
  • Arthur J. Gallagher & Co
  • BioAdvance
  • BLA Regulatory
  • Carta
  • Celerion
  • Frontage Laboratories
  • Johnson & Johnson
  • Lyophilization Technology
  • Medix
  • Merck Foundation
  • Merrill Lynch
  • Network for Good
  • Poretta & Orr
  • Tunnell Consulting
  • United States Department of Defense

  1. About Us. Blumberg Institute. Retrieved June 26, 2023, from https://web.archive.org/web/20230626071723/https://www.blumberginstitute.org/about/our-mission/ ↩︎ ↩︎

  2. Cohen, C. (2023). 2022 Annual Report (pp. 18–21). Hepatitis B Foundation. https://web.archive.org/web/20230314121341/https://www.hepb.org/assets/Uploads/HepB-2022-Annual-Report-v1-2.21.23.pdf ↩︎

  3. Block, T. M. (2022, July 6). Annual Report 2021. Issuu; Hepatitis B Foundation. https://web.archive.org/web/20230626072726/https://issuu.com/hepbfoundation/docs/hepb-2021_annual_report-v8_7-6 ↩︎

  4. Block, T. M., & Rosen, J. 2020 Annual Report. Hepatitis B Foundation. Retrieved June 26, 2023, from https://web.archive.org/web/20230626232802/https://www.hepb.org/assets/Uploads/HepB-2020-Annual-Report-FINAL2.pdf ↩︎